Single dose of EDIT-401 achieved ~90% or greater mean reductions in LDL-C, Lp(a), and ApoB in non-human primates Data ...

In an early-stage trial involving 35 high-risk patients, LDL or bad cholesterol fell by up to 62% after a single infusion of ...

Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.

Eli Lilly said it received positive results from its phase 1b clinical trials for its experimental gene editing treatment for high cholesterol. The pharmaceutical company said Monday that a single ...

Eli Lilly is laying the groundwork for a phase 2 trial of the lipid-lowering gene editor it acquired from Verve Therapeutics, with the candidate now showing strong and consistent cholesterol ...

If your doctor has ever told you to "keep an eye on your numbers," here's good news: The rules around what’s considered high ...

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.

Venture capitalist Chamath Palihapitiya responded “What?!?!?!” on X, amplifying analyst Cremieux‘s post describing Eli Lilly ...

Eli Lilly said its experimental gene-editing therapy cut LDL, or “bad,” cholesterol by up to 62% in an early-stage trial, ...

In an early-stage trial, one infusion of the therapy resulted in reduced PCSK9 levels by up to 88% and LDL cholesterol by up ...

Persons carrying loss-of-function variants of proprotein convertase subtilisin–kexin type 9 (PCSK9) have reduced levels of low-density lipoprotein (LDL) cholesterol and fewer atherosclerotic ...

Many foods we consider healthy and natural can actually raise cholesterol levels. But it doesn't mean we should cut them out ...